The aberrant expression of DUX4 in FSHD has been proposed to inhibit myogenesis by suppressing Myod regulated pathways and inducing muscle atrophy pathways [20,24,28-33]. The gene discussed is MYOD1; the disease is facioscapulohumeral muscular dystrophy.